SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-100803
Filing Date
2023-09-14
Accepted
2023-09-14 16:31:11
Documents
13
Period of Report
2023-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326158d1_8k.htm   iXBRL 8-K 28135
2 EXHIBIT 99.1 tm2326158d1_ex99-1.htm EX-99.1 10127
  Complete submission text file 0001104659-23-100803.txt   216473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA axla-20230914.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20230914_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20230914_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2326158d1_8k_htm.xml XML 3290
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 231255472
SIC: 2836 Biological Products, (No Diagnostic Substances)